Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, Hanka Venselaar, Henrich van der Lee, Yinggai Song, Chao Tang, Auke W de Jong, Yingqian Kang, Paul E Verweij, G S de Hoog, Jochem B Buil
{"title":"荷兰黄曲霉(Aspergillus Section Flavi) 1994-2023年环境三唑抗性选择途径尚无证据。","authors":"Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, Hanka Venselaar, Henrich van der Lee, Yinggai Song, Chao Tang, Auke W de Jong, Yingqian Kang, Paul E Verweij, G S de Hoog, Jochem B Buil","doi":"10.1007/s11046-025-01003-y","DOIUrl":null,"url":null,"abstract":"<p><p>Aspergillus section Flavi comprises opportunistic pathogens such as Aspergillus flavus, posing significant health risks. Unlike A. fumigatus, where environmental selection drives widespread resistance, it is uncertain whether A. flavus develops azole resistance through a similar environmental route. This study analyzed 544 Aspergillus section Flavi isolates collected from 534 patients in Dutch hospitals (1994-2023). Calmodulin sequencing was used for molecular identification. Antifungal susceptibility testing (AFST) was performed according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. Cyp51A was sequenced and mutations were mapped onto the CYP 51 protein 3D model for azole-resistant or non-wild-type isolates. Clinical data, including azole exposure history and underlying diseases, were correlated with the resistance profiles. Of the 544 isolates, 520 were identified as A. flavus and 24 as related species, including A. tamarii (16), A. parasiticus (3), A. nomiae (2), A. pseudonomiae (2), and A. pseudocaelatus (1). Fourteen isolates from five patients were azole-resistant/non-WT, with resistance rates ranging from 0.2 to 0.8%. Resistant/non-WT isolates were associated with chronic diseases and prior clinical azole exposure. Among 10 patients with proven/probable invasive aspergillosis azole resistance was not observed. Two main Cyp51A-SNPs were found in azole-resistant isolates: Y119F and T329A. Aspergillus flavus was the dominant pathogenic species within the section Flavi with low levels of azole resistance. Distribution of resistant cases supports in host resistance selection rather than environmental selection. These findings highlight the need for further research on the ecological and molecular factors that influence resistance in A. flavus.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"99"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"No Evidence for Environmental Triazole Resistance Selection Route in Aspergillus Section Flavi, The Netherlands, 1994-2023.\",\"authors\":\"Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, Hanka Venselaar, Henrich van der Lee, Yinggai Song, Chao Tang, Auke W de Jong, Yingqian Kang, Paul E Verweij, G S de Hoog, Jochem B Buil\",\"doi\":\"10.1007/s11046-025-01003-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Aspergillus section Flavi comprises opportunistic pathogens such as Aspergillus flavus, posing significant health risks. Unlike A. fumigatus, where environmental selection drives widespread resistance, it is uncertain whether A. flavus develops azole resistance through a similar environmental route. This study analyzed 544 Aspergillus section Flavi isolates collected from 534 patients in Dutch hospitals (1994-2023). Calmodulin sequencing was used for molecular identification. Antifungal susceptibility testing (AFST) was performed according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. Cyp51A was sequenced and mutations were mapped onto the CYP 51 protein 3D model for azole-resistant or non-wild-type isolates. Clinical data, including azole exposure history and underlying diseases, were correlated with the resistance profiles. Of the 544 isolates, 520 were identified as A. flavus and 24 as related species, including A. tamarii (16), A. parasiticus (3), A. nomiae (2), A. pseudonomiae (2), and A. pseudocaelatus (1). Fourteen isolates from five patients were azole-resistant/non-WT, with resistance rates ranging from 0.2 to 0.8%. Resistant/non-WT isolates were associated with chronic diseases and prior clinical azole exposure. Among 10 patients with proven/probable invasive aspergillosis azole resistance was not observed. Two main Cyp51A-SNPs were found in azole-resistant isolates: Y119F and T329A. Aspergillus flavus was the dominant pathogenic species within the section Flavi with low levels of azole resistance. Distribution of resistant cases supports in host resistance selection rather than environmental selection. These findings highlight the need for further research on the ecological and molecular factors that influence resistance in A. flavus.</p>\",\"PeriodicalId\":19017,\"journal\":{\"name\":\"Mycopathologia\",\"volume\":\"190 6\",\"pages\":\"99\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mycopathologia\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1007/s11046-025-01003-y\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MYCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycopathologia","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s11046-025-01003-y","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MYCOLOGY","Score":null,"Total":0}
No Evidence for Environmental Triazole Resistance Selection Route in Aspergillus Section Flavi, The Netherlands, 1994-2023.
Aspergillus section Flavi comprises opportunistic pathogens such as Aspergillus flavus, posing significant health risks. Unlike A. fumigatus, where environmental selection drives widespread resistance, it is uncertain whether A. flavus develops azole resistance through a similar environmental route. This study analyzed 544 Aspergillus section Flavi isolates collected from 534 patients in Dutch hospitals (1994-2023). Calmodulin sequencing was used for molecular identification. Antifungal susceptibility testing (AFST) was performed according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. Cyp51A was sequenced and mutations were mapped onto the CYP 51 protein 3D model for azole-resistant or non-wild-type isolates. Clinical data, including azole exposure history and underlying diseases, were correlated with the resistance profiles. Of the 544 isolates, 520 were identified as A. flavus and 24 as related species, including A. tamarii (16), A. parasiticus (3), A. nomiae (2), A. pseudonomiae (2), and A. pseudocaelatus (1). Fourteen isolates from five patients were azole-resistant/non-WT, with resistance rates ranging from 0.2 to 0.8%. Resistant/non-WT isolates were associated with chronic diseases and prior clinical azole exposure. Among 10 patients with proven/probable invasive aspergillosis azole resistance was not observed. Two main Cyp51A-SNPs were found in azole-resistant isolates: Y119F and T329A. Aspergillus flavus was the dominant pathogenic species within the section Flavi with low levels of azole resistance. Distribution of resistant cases supports in host resistance selection rather than environmental selection. These findings highlight the need for further research on the ecological and molecular factors that influence resistance in A. flavus.
期刊介绍:
Mycopathologia is an official journal of the International Union of Microbiological Societies (IUMS). Mycopathologia was founded in 1938 with the mission to ‘diffuse the understanding of fungal diseases in man and animals among mycologists’. Many of the milestones discoveries in the field of medical mycology have been communicated through the pages of this journal. Mycopathologia covers a diverse, interdisciplinary range of topics that is unique in breadth and depth. The journal publishes peer-reviewed, original articles highlighting important developments concerning medically important fungi and fungal diseases. The journal highlights important developments in fungal systematics and taxonomy, laboratory diagnosis of fungal infections, antifungal drugs, clinical presentation and treatment, and epidemiology of fungal diseases globally. Timely opinion articles, mini-reviews, and other communications are usually invited at the discretion of the editorial board. Unique case reports highlighting unprecedented progress in the diagnosis and treatment of fungal infections, are published in every issue of the journal. MycopathologiaIMAGE is another regular feature for a brief clinical report of potential interest to a mixed audience of physicians and laboratory scientists. MycopathologiaGENOME is designed for the rapid publication of new genomes of human and animal pathogenic fungi using a checklist-based, standardized format.